BTAI vs LTRN (BioXcel Therapeutics Inc. vs Lantern Pharma Inc.)
Showing Closing Date Range from Sep, 16 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
US Market Trading Session Active
Active trading session is live as of 11:56 AM ET. Prices update dynamically and reflect the latest trade records across major US exchanges. Official closing prices settle after 4:00 PM ET.
BTAI leads by +55.88% Alpha Spread Today
BTAI is trading at +49.66% while LTRN is at -6.22% .
Started At
Official opening auction price
Last Recorded Trade Price
Last recorded trade as of 11:56 AM ET
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | BTAI | LTRN | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | +49.66% | -6.22% | BTAI +55.88% |
| Net Dollar Move | +$0.02 | $-0.12 | BTAI higher move |
| Open Price | $0.05 | $1.93 | Gap: 25.00% vs 0.00% |
| Day High | $0.07 | $1.93 | Session peaks |
| Day Low | $0.04 | $1.74 | Session troughs |
| Intraday Spread | $0.03 | $0.19 | High/Low spread |
| Share Volume | 1.12M | 127.8K | BTAI more active |
| Est. Dollar Volume | $78.1K | $231.3K | LTRN higher liquidity |
Explore BTAI vs LTRN Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.